Epizyme, Inc.·4

May 11, 2:27 PM ET

Epizyme, Inc. 4

4 · Epizyme, Inc. · Filed May 11, 2017

Insider Transaction Report

Form 4
Period: 2017-05-09
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2017-05-09+1,68240,316 total
  • Exercise/Conversion

    Common Stock, par value $0.0001

    2017-05-09+77841,094 total
  • Exercise/Conversion

    Restricted Stock Units

    2017-05-091,68235,320 total
    Common Stock (1,682 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2017-05-0977816,324 total
    Common Stock (778 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Epizyme, Inc. common stock upon vesting.
  • [F2]This award, granted on February 9, 2016, pursuant to the Company's 2013 Stock Incentive plan, vests as to 25% of the total award on February 9, 2016, a year from the commencement of employment, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.
  • [F3]This award, granted on February 9, 2015, pursuant to the Company's 2013 Stock Inventive Plan, vests as to 25% of the total award on February 9, 2016, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION